The American Journal of Managed Care

Patients With Actinic Keratosis Prefer Simulated Daylight PDT Over More Painful Red Light PDT

A recent study found that patients with actinic keratosis experienced more pain during red light photodynamic therapy (PDT) than simulated daylight PDT, emphasizing the need to understand patient ...
clinicaladvisor.com

Actinic Keratoses: Field Cancerization and Photodynamic Therapy

Patients undergoing in-office treatment with PDT will have their skin cleansed with acetone and then undergo ALA application to the targeted treatment area. Incubation times will vary based on ...
Healio

Long-term efficacy highest for PDT with aminolevulinate for actinic keratosis

Please provide your email address to receive an email when new articles are posted on . Photodynamic therapy with aminolevulinate and imiquimod are among the treatments with good long-term efficacy ...
Healio

Seasonal changes may dictate utilization of photodynamic therapy for actinic keratoses

Please provide your email address to receive an email when new articles are posted on . More photodynamic therapy (PDT) sessions were performed during winter vs. summer. Southern states saw the least ...
Nasdaq

Biofrontera Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk

WOBURN, MA / ACCESSWIRE / January 9, 2023 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that the first ...
Monthly Prescribing Reference

For Actinic Keratoses, Photodynamic Therapy Beats Cryotherapy

(HealthDay News) — For actinic keratoses (AKs), photodynamic therapy (PDT) is associated with improved response compared with cryotherapy, according to a meta-analysis published online August 27 in ...
Seeking Alpha

Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk

WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the ...
Nasdaq

Biofrontera Inc. Completes Patient Enrollment in Phase 3 Trial for Ameluz® in Treating Actinic Keratoses on Neck, Trunk, and Extremities

Biofrontera Inc. has completed enrollment for its Phase 3 clinical trial of Ameluz® photodynamic therapy (PDT), aiming to treat mild to moderate actinic keratoses (AKs) on the neck, trunk, and ...
Yahoo Finance

Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities

Completion of this study marks a key milestone towards a planned summer 2026 FDA submission for FDA approval for the use of Ameluz ® on all non-face and scalp areas WOBURN, Mass., Dec. 04, 2025 (GLOBE ...
MedPage Today

New Clarity on the Relative Efficacy of Rx Options for Actinic Keratoses, Especially for SCC Prevention

We are fortunate to have treatment options to consider for individuals with multiple actinic keratoses. When counseling patients, however, their relative efficacy has been unclear, particularly for ...
Business Insider

Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities

Phase 1 Maximal-use Phase 1 study evaluated pharmacokinetic (PK) profile following application of 3 tubes of Ameluz ® over treatment area of 240 cm 2 Completion of this study marks a key milestone ...